Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Lamivudine")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 1808

  • Page / 73
Export

Selection :

  • and

Pharmacokinetic profiling and bioequivalence evaluation of 2 lamivudine tablet formulations after single oral administration in healthy human Indian volunteersNARANG, Vishal S; LULLA, Amar; MALHOTRA, Geena et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 38, Num 5, pp 566-569, issn 1525-4135, 4 p.Article

Spontaneous recovery of hemoglobin and neutrophil levels in Japanese patients on a long-term Combivir® containing regimenMATSUSHITA, Shuzo; YOSHIMURA, Kazuhisa; KIMURA, Tetsuya et al.Journal of clinical virology. 2005, Vol 33, Num 3, pp 188-193, issn 1386-6532, 6 p.Article

Prior Therapy Influences the Efficacy of Lamivudine Monotherapy in Patients with Lamivudine-resistant HIV-1 InfectionOPRAVIL, Milos; KLIMKAIT, Thomas; LOUVEL, Severine et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 54, Num 1, pp 51-58, issn 1525-4135, 8 p.Article

Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Compared With Zidovudine/Lamivudine and Efavirenz in Treatment-Naive Patients : 144-Week AnalysisARRIBAS, Jose R; POZNIAK, Anton L; TOOLE, John J et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 47, Num 1, pp 74-78, issn 1525-4135, 5 p.Article

Predictors of Loss of Virologic Response in Subjects Who Simplified to Lopinavir/Ritonavir Monotherapy from Lopinavir/Ritonavir Plus Zidovudine/LamivudineCAMPO, Rafael E; DA SILVA, Barbara A; COTTE, Laurent et al.AIDS research and human retroviruses. 2009, Vol 25, Num 3, pp 269-275, issn 0889-2229, 7 p.Article

Comparison of Once-Daily Fosamprenavir Boosted with Either 100 or 200 mg of Ritonavir, in Combination with Abacavir/Lamivudine : 96-Week Results from COL100758HICKS, Charles B; DEJESUS, Edwin; SLOAN, Louis M et al.AIDS research and human retroviruses. 2009, Vol 25, Num 4, pp 395-403, issn 0889-2229, 9 p.Article

Long-Term Assessment of Didanosine, Lamivudine, and Efavirenz in Antiretroviral-Naive Patients : 3-Year Follow-UpSANTOS, Jesus; PALACIOS, Rosario; LOZANO, Fernando et al.AIDS research and human retroviruses. 2008, Vol 24, Num 1, pp 24-26, issn 0889-2229, 3 p.Article

Long-term efficacy and safety of atazanavir with stavudine and lamivudine in patients previously treated with nelfinavir or atazanavirWOOD, Robin; PHANUPHAK, Praphan; GIORDANO, Michael et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 36, Num 2, pp 684-692, issn 1525-4135, 9 p.Article

Sensitive line probe assay that simultaneously detects mutations conveying resistance to lamivudine and adefovirHUSSAIN, Munira; FUNG, Scott; LIBBRECHT, Evelien et al.Journal of clinical microbiology (Print). 2006, Vol 44, Num 3, pp 1094-1097, issn 0095-1137, 4 p.Article

Lack of Minority K65R-Resistant Viral Populations Detected After Repeated Treatment Interruptions of Tenofovir/Zidovudine and Lamivudine in a Resource-Limited SettingMCCORMICK, Adele L; GOODALL, Ruth L; JOYCE, Aengus et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 54, Num 2, pp 215-217, issn 1525-4135, 3 p.Article

Quantitative determination and sampling of lamivudine and zidovudine residues for cleaning validation in a production areaROCHA MIRITELLO SANTORO, Maria Inês; FAZIO, Tatiana Tatit; ANIL KUMAR SINGH et al.Journal of AOAC International. 2007, Vol 90, Num 3, pp 715-719, issn 1060-3271, 5 p.Article

A facile and effective synthesis of lamivudine 5'-diphosphateROY, Béatrice; LEFEBVRE, Isabelle; PUY, Jean-Yves et al.Tetrahedron letters. 2011, Vol 52, Num 12, issn 0040-4039, 1233, 1250-1252 [4 p.]Article

Rapid detection of drug-resistant mutations in hepatitis B virus by the PCR-Invader assayTADOKORO, Kenichi; SUZUKI, Fumitaka; KOBAYASHI, Mariko et al.Journal of virological methods. 2011, Vol 171, Num 1, pp 67-73, issn 0166-0934, 7 p.Article

Differential inhibition of lamivudine-resistant hepatitis B virus by allele-specific RNAiXU TENG; XU, Wei-Zhen; HAO, Mei-Li et al.Journal of virological methods. 2010, Vol 168, Num 1-2, pp 6-12, issn 0166-0934, 7 p.Article

The rtL229 substitutions in the reverse transcriptase region of hepatitis B virus (HBV) polymerase are potentially associated with lamivudine resistance as a compensatory mutationDONG JI; YAN LIU; CHEN, Guo-Feng et al.Journal of clinical virology. 2012, Vol 54, Num 1, pp 66-72, issn 1386-6532, 7 p.Article

Simultaneous detection of two major lamivudine-resistant mutants using competitively differentiated-PCRXIAO MOU PENG; LIN GU; YANG SU HUANG et al.Journal of virological methods. 2005, Vol 128, Num 1-2, pp 168-175, issn 0166-0934, 8 p.Article

Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosaGUILLEVIN, L; MAHR, A; PETITJEAN, P et al.Arthritis care and research. 2004, Vol 51, Num 3, pp 482-487, issn 0893-7524, 6 p.Article

Lack of antagonism between abacavir, lamivudine, and tenofovir against wild-type and drug-resistant HIV-1LANIER, E. Randall; HAZEN, Richard; ROSS, Lisa et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 39, Num 5, pp 519-522, issn 1525-4135, 4 p.Article

Tenofovir disoproxil fumarate, emtricitabine, and efavirenz versus fixed-dose zidovudine/lamivudine and efavirenz in antiretroviral-naive patients : Virologic, immunologic, and morphologic changes-A 96-week analysisPOZNIAK, Anton L; GALLANT, Joel E; CHENG, Andrew K et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 43, Num 5, pp 535-540, issn 1525-4135, 6 p.Article

Mutation analysis of lamivudine resistant hepatitis B virus strains by TaqMan PCRMALMSTRÖM, Sebastian; HANNOUN, Charles; LINDH, Magnus et al.Journal of virological methods. 2007, Vol 143, Num 2, pp 147-152, issn 0166-0934, 6 p.Article

Hepatitis B virus genotyping based on cluster analysis of the region involved in lamivudine resistanceRODRIGUEZ-NOVOA, Sonia; GOMEZ-TATO, Antonio; AGUILERA-GUIRAO, Antonio et al.Journal of virological methods. 2004, Vol 115, Num 1, pp 9-17, issn 0166-0934, 9 p.Article

Should Lamivudine Monotherapy be Stopped or Continued in Patients Infected With Hepatitis B With Favorable Responses After More Than 5 Years of Treatment?JUNG HYUN KWON; JEONG WON JANG; JONG YOUNG CHOI et al.Journal of medical virology. 2013, Vol 85, Num 1, pp 34-42, issn 0146-6615, 9 p.Article

Molecular Characterization of Hepatitis B Virus and a 9-Year Clinical Profile in a Patient Infected With Genotype IOSIOWY, Carla; KAITA, Kelly; SOLAR, Kaarina et al.Journal of medical virology. 2010, Vol 82, Num 6, pp 942-948, issn 0146-6615, 7 p.Article

Efficacy and Safety of Atazanavir, With or Without Ritonavir, as Part of Once-Daily Highly Active Antiretroviral Therapy Regimens in Antiretroviral-Naive PatientsMALAN, D. R; KRANTZ, Edrich; DAVID, Neal et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 47, Num 2, pp 161-167, issn 1525-4135, 7 p.Article

Lamivudine prophylaxis and treatment of hepatitis B virus-exposed recipients receiving reduced intensity conditioning hematopoietic stem cell transplants with alemtuzumabMOSES, S. E; LIM, Z. Y; SUDHANVA, M et al.Journal of medical virology. 2006, Vol 78, Num 12, pp 1560-1563, issn 0146-6615, 4 p.Article

  • Page / 73